← All State Street CORP filings

State Street CORP Schedule 13G passive stakes

NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 4.8% Stake in Sabra Health Care REIT
State Street Corporation has reported a 4.8% beneficial ownership stake in Sabra Health Care REIT Inc. as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 4.4% Stake in Royal Gold Inc.
State Street Corporation has reported a 4.4% beneficial ownership stake in Royal Gold Inc. common stock as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 4.9% Stake in Rexford Industrial
State Street Corporation has reported a 4.9% beneficial ownership stake in Rexford Industrial Realty Inc. common stock as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5% Stake in Renasant Corp
State Street Corporation has reported a 5% beneficial ownership stake in Renasant Corp common stock as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.2% Stake in Reliance Inc.
State Street Corporation has reported a 5.2% beneficial ownership stake in Reliance Inc.'s common stock as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.5% Stake in Red Cat Holdings
State Street Corporation has reported a passive 5.5% beneficial ownership stake in Red Cat Holdings Inc., holding over 6.6 million shares.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.2% Stake in PTC Therapeutics
State Street Corporation has reported a 5.2% beneficial ownership stake in PTC Therapeutics Inc., holding over 4.2 million shares.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 6.1% Stake in Power Integrations
State Street Corporation has reported a 6.1% beneficial ownership stake in Power Integrations Inc., held for investment purposes.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.8% Stake in Pathward Financial
State Street Corporation has reported a 5.8% beneficial ownership stake in Pathward Financial Inc., holding 1,294,836 shares of common stock.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5% Stake in ONE GAS INC
State Street Corporation has reported a 5% beneficial ownership stake in ONE GAS INC, holding 2,983,016 shares of common stock as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.9% Stake in Novavax
State Street Corporation has reported a 5.9% beneficial ownership stake in Novavax Inc., holding over 9.5 million shares as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 6% Stake in NNN REIT INC
State Street Corporation has reported a 6% beneficial ownership stake in NNN REIT INC, holding 11,449,621 shares of common stock as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 7.2% Stake in News Corp
State Street Corporation has reported a 7.2% beneficial ownership stake in News Corp's common stock as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 6.4% Stake in Myriad Genetics
State Street Corporation has reported a 6.4% beneficial ownership stake in Myriad Genetics Inc. common stock as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 4.7% Stake in Moog Inc.
State Street Corporation has reported a 4.7% beneficial ownership stake in Moog Inc. common stock as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 4.8% Passive Stake in Molson Coors
State Street Corporation has reported a passive beneficial ownership of 4.8% in Molson Coors Beverage Co. common stock as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.1% Stake in McDonald's
State Street Corporation has reported a 5.1% beneficial ownership stake in McDonald's Corp common stock as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 6.9% Passive Stake in Match Group
State Street Corporation has reported a 6.9% passive beneficial ownership stake in Match Group Inc., held through its various investment advisory subsidiaries.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.1% Stake in M/I Homes
State Street Corporation has disclosed a 5.1% beneficial ownership stake in M/I Homes Inc., holding 1,337,188 shares of common stock.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.7% Stake in LXP Industrial Trust
State Street Corporation has reported a 5.7% beneficial ownership stake in LXP Industrial Trust's common stock, held in the ordinary course of business.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 4.7% Stake in Live Nation
State Street Corporation has reported a 4.7% beneficial ownership stake in Live Nation Entertainment Inc. as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.7% Stake in Lightbridge Corp
State Street Corporation has reported a 5.7% beneficial ownership stake in Lightbridge Corp, holding 1,847,661 common shares.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5% Stake in Lakeland Financial
State Street Corporation has reported a 5% beneficial ownership stake in Lakeland Financial Corp, holding 1,274,040 shares of common stock.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.7% Stake in Kura Oncology
State Street Corporation has reported a 5.7% beneficial ownership stake in Kura Oncology Inc., holding 4,931,090 shares as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.1% Stake in Kroger
State Street Corporation has reported a 5.1% beneficial ownership stake in The Kroger Co., holding over 31.9 million shares as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 4.9% Stake in Kratos Defense
State Street Corporation has reported a 4.9% beneficial ownership stake in Kratos Defense & Security Solutions Inc., holding over 8.19 million common shares.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 6.1% Stake in Kopin Corp
State Street Corporation has reported a 6.1% beneficial ownership stake in Kopin Corp, holding over 11 million common shares.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 6.4% Stake in Janux Therapeutics
State Street Corporation has reported a 6.4% beneficial ownership stake in Janux Therapeutics Inc. common stock as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.1% Stake in Iovance Biotherapeutics
State Street Corporation has reported a 5.1% beneficial ownership stake in Iovance Biotherapeutics Inc., holding over 20 million common shares as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.5% Stake in Intellia Therapeutics
State Street Corporation has reported a 5.5% beneficial ownership stake in Intellia Therapeutics Inc. as of December 31, 2025.